These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 11808833
1. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital. Mitra S, Findley K, Frohnapple D, Mehta JL. Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833 [Abstract] [Full Text] [Related]
2. Trends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical Center. Bansal D, Gaddam V, Aude YW, Bissett J, Fahdi I, Garza L, Joseph J, Molavi B, Pai BV, Sinha A, Smith ES, Mehta JL. J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):39-44. PubMed ID: 15821837 [Abstract] [Full Text] [Related]
3. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Barron HV, Michaels AD, Maynard C, Every NR. J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461 [Abstract] [Full Text] [Related]
4. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939 [Abstract] [Full Text] [Related]
5. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre. Haddad H, Searles G, Gillis A. Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488 [Abstract] [Full Text] [Related]
6. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666 [Abstract] [Full Text] [Related]
13. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Shore S, Jones PG, Maddox TM, Bradley SM, Stolker JM, Arnold SV, Parashar S, Peterson P, Bhatt DL, Spertus J, Ho PM. Heart; 2015 May 15; 101(10):800-7. PubMed ID: 25801001 [Abstract] [Full Text] [Related]
14. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease. Sanal S, Aronow WS. J Gerontol A Biol Sci Med Sci; 2003 Nov 15; 58(11):1046-8. PubMed ID: 14630888 [Abstract] [Full Text] [Related]
17. Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction. Majumdar SR, Inui TS, Gurwitz JH, Gillman MW, McLaughlin TJ, Soumerai SB. J Gen Intern Med; 2001 Jun 15; 16(6):351-9. PubMed ID: 11422631 [Abstract] [Full Text] [Related]